Myopia has reached epidemic proportions in the world, especially in East Asia. Pathologic myopia is an extreme type of high myopia that can cause irreversible blindness. Myopic maculopathy is one of the characteristics of pathologic myopia. Nowadays, limited treatments can preserve the visual outcome of these patients. We review the current treatment in practice for myopic maculopathy. Furthermore, based on the current stem cell -based therapy used in degenerative ocular diseases, we discuss a new concept of stem cell therapy for myopic maculopathy.
基金：
National Key RD Project [2017YFA0105300]; Beijing Natural Science Foundation [Z200014]; National Natural Science Foundation of China [82125007]
第一作者机构：[1]Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr,Beijing Ophthalmol & Visua, Hougou Lane 17, Beijing 100730, Peoples R China
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Tongren Hosp, Beijing Inst Ophthalmol, Beijing Tongren Eye Ctr,Beijing Ophthalmol & Visua, Hougou Lane 17, Beijing 100730, Peoples R China[*1]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmology & Visual Science Key Laboratory, Hougou Lane 17#, Dongcheng District, Beijing 100730, China
推荐引用方式(GB/T 7714)：
Ma Ya,Li Yan-Ping,Jin Zi-Bing.Stem cell-based therapy for myopic maculopathy: a new concept[J].JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS.2022,6(2):179-203.doi:10.20517/jtgg.2021.48.
APA：
Ma, Ya,Li, Yan-Ping&Jin, Zi-Bing.(2022).Stem cell-based therapy for myopic maculopathy: a new concept.JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS,6,(2)
MLA：
Ma, Ya,et al."Stem cell-based therapy for myopic maculopathy: a new concept".JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS 6..2(2022):179-203
